Literature DB >> 18259864

RDW as an additional marker in inflammatory bowel disease/undifferentiated colitis.

Kofi Clarke1, Rabindra Sagunarthy, Sheru Kansal.   

Abstract

BACKGROUND: Anemia is a common complication in inflammatory bowel disease patients. We postulate that the distribution of lesions in Crohn's disease is more likely than ulcerative colitis to lead to malabsorption as an additional cause of anemia. RDW, a simple and inexpensive test could be an additional differentiating test. METHODS AND
RESULTS: Retrospective review of 284 cases of which 156 cases were diagnosed with Crohn's disease and 128 cases were diagnosed with ulcerative colitis. There was a significant difference in the mean RDW between the Crohn's and the ulcerative colitis cases (14.9 vs. 14.3, P = .027).
CONCLUSIONS: We conclude there is a statistical significance between the two groups though this may not represent a clinically significant difference. From our analysis we conclude that RDW is statistically significant and with the implementation of a more rigorous study design and analysis of further data RDW may prove to be a clinically effective marker in differentiating Crohn's disease from ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259864     DOI: 10.1007/s10620-007-0176-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  6 in total

1.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Authors:  M Peeters; S Joossens; S Vermeire; R Vlietinck; X Bossuyt; P Rutgeerts
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

Review 2.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Anemia in patients with chronic inflammatory bowel disease.

Authors:  C C Cronin; F Shanahan
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

Review 4.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

5.  Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.

Authors:  Anna Zholudev; David Zurakowski; Wes Young; Alan Leichtner; Athos Bousvaros
Journal:  Am J Gastroenterol       Date:  2004-11       Impact factor: 10.864

Review 6.  Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature.

Authors:  Alisa Wilson; Eileen Reyes; Josh Ofman
Journal:  Am J Med       Date:  2004-04-05       Impact factor: 4.965

  6 in total
  20 in total

1.  Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.

Authors:  Chang Seok Song; Dong Il Park; Min Yong Yoon; Hyo Sun Seok; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis.

Authors:  Tamás Molnar; Klaudia Farkas; Zoltán Szepes; Ferenc Nagy; Tibor Nyari; Tibor Wittmann
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

3.  Red cell distribution width: a novel predictive biomarker for stroke risk after transient ischaemic attack.

Authors:  Ke-Hang Xie; Ling-Ling Liu; Yun-Ru Liang; Chu-Yin Su; Hua Li; Run-Ni Liu; Qing-Qing Chen; Jia-Sheng He; Yong-Kun Ruan; Wang-Kai He
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

4.  Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis.

Authors:  Yujue He; Can Liu; Zhiyong Zeng; Weilin Ye; Jinpiao Lin; Qishui Ou
Journal:  Clin Rheumatol       Date:  2017-11-03       Impact factor: 2.980

5.  Can red cell distribution width be a marker of disease activity in ulcerative colitis?

Authors:  Serkan Ipek; Cem Cekic; Emrah Alper; Eyup Coban; Eylem Eliacik; Mahmut Arabul; Fatih Aslan; Sezgin Vatansever; Hulya Yalcin; Belkis Unsal
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease.

Authors:  P H A Bours; J P M Wielders; J R Vermeijden; A van de Wiel
Journal:  Osteoporos Int       Date:  2010-11-27       Impact factor: 4.507

7.  Red cell distribution width: a novel marker of activity in inflammatory bowel disease.

Authors:  Atakan Yeşil; Ebubekir Senateş; Ibrahim Vedat Bayoğlu; Emrullah Düzgün Erdem; Refik Demirtunç; Ayşe Oya Kurdaş Övünç
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

8.  Red cell distribution width is an independent factor for left ventricular diastolic dysfunction in patients with chronic kidney disease.

Authors:  Leszek Gromadziński; Beata Januszko-Giergielewicz; Piotr Pruszczyk
Journal:  Clin Exp Nephrol       Date:  2014-09-25       Impact factor: 2.801

9.  Elevated red blood cell distribution width and inflammation in printing workers.

Authors:  Ahmet Celik; Neriman Aydin; Birgul Ozcirpici; Edibe Saricicek; Hatice Sezen; Mehmet Okumus; Selim Bozkurt; Metin Kilinc
Journal:  Med Sci Monit       Date:  2013-11-15

10.  Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome.

Authors:  Gulali Aktas; Aytekin Alcelik; Buket Kin Tekce; Vildan Tekelioglu; Mustafa Sit; Haluk Savli
Journal:  Prz Gastroenterol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.